KinderCare Learning Companies Inc (NYSE: KLC) is under fire Thursday following a new report from The Bear Cave, which alleges safety failures, regulatory concerns and a deteriorating reputation at the nation's largest private childcare provider.
The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and Camp4 Therapeutics each made their public debut.
